— Research Library —
The research record, plainly written.
Every compound on bhc.supply is documented in a research note: mechanism, history, and references — written in third-person scientific context, drawn from the published literature. No marketing, no anecdotes, no dosing advice. Just the record.
peptide
29 articlespeptide
GHK-Cu
Endogenous tripeptide-copper(II) complex investigated in dermatology, wound-healing, and gene-expression research since its discovery in 1973.
peptide
Tesamorelin
N-terminally modified GHRH analog investigated in clinical research for HIV-associated visceral adipose tissue and metabolic endpoints.
peptide
GHRP-2
Synthetic hexapeptide ghrelin receptor agonist investigated for potent growth hormone-releasing activity with characterized cortisol and prolactin effects.
peptide
Retatrutide
Single-molecule triple agonist of the GLP-1, GIP, and glucagon receptors investigated in clinical trials for body-weight regulation and glycemic control.
peptide
BPC-157
Synthetic 15-residue peptide derived from a gastric juice protein fragment, investigated in preclinical models for tissue repair, angiogenesis, and gastrointestinal protection.
peptide
5-Amino-1MQ
Small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) investigated for adipose tissue metabolism in preclinical obesity research.
peptide
Melanotan II
Cyclic heptapeptide alpha-MSH analog developed at the University of Arizona, investigated as a non-selective melanocortin receptor agonist.
peptide
Tirzepatide
Dual GIP and GLP-1 receptor co-agonist investigated for glycemic regulation and body-weight reduction in advanced clinical trials.
peptide
MOTS-c
Mitochondrial-derived 16-amino-acid peptide investigated for AMPK activation, metabolic regulation, and age-related research applications.
peptide
TB-500
Synthetic analog of thymosin beta-4 investigated for actin sequestration, angiogenesis, and tissue repair in preclinical research models.
peptide
Pentadeca Arginate (PDA)
Arginate salt form of a BPC-related pentadecapeptide investigated in early research contexts for tissue repair and stability characteristics.
peptide
Semaglutide
Long-acting GLP-1 receptor agonist with extensive clinical research in glycemic control, body-weight regulation, and cardiovascular endpoints.
peptide
Cagrilintide
Long-acting amylin receptor agonist investigated as a monotherapy and in fixed-combination research with semaglutide for body-weight regulation.
peptide
AOD-9604
Modified C-terminal fragment of human growth hormone (residues 176-191) investigated for lipolytic activity decoupled from somatogenic effects.
peptide
Semax
Heptapeptide ACTH(4-10) analog developed by the Russian Academy of Sciences investigated for nootropic and neurotrophic research applications.
peptide
Dihexa
Orally bioavailable angiotensin IV analog investigated as a small-molecule hepatocyte growth factor mimetic in preclinical neuroscience research.
peptide
Selank
Russian-developed synthetic heptapeptide analog of tuftsin investigated in preclinical and Russian clinical research for anxiolytic and neuromodulatory effects.
peptide
KPV
Tripeptide C-terminal fragment of alpha-MSH investigated for anti-inflammatory activity in epithelial and mucosal research models.
peptide
CJC-1295 with DAC
Long-acting GHRH analog incorporating a drug affinity complex for albumin binding, investigated for sustained growth hormone axis activation.
peptide
MOD-GRF (CJC-1295 no DAC)
Stabilized 29-amino-acid GHRH analog (modified GRF 1-29) used in research as a short-acting probe of growth hormone secretion.
peptide
Ipamorelin
Selective pentapeptide ghrelin receptor agonist investigated as a growth hormone secretagogue with minimal effects on cortisol and prolactin.
peptide
Hexarelin
Hexapeptide ghrelin receptor agonist investigated as a potent growth hormone secretagogue with cardiovascular research interest.
peptide
Sermorelin
Synthetic 29-amino-acid N-terminal fragment of native GHRH investigated as the minimal bioactive sequence for growth hormone-releasing activity.
peptide
GHRP-6
First-generation hexapeptide ghrelin receptor agonist that helped establish the synthetic secretagogue receptor pharmacology field.
peptide
Cerebrolysin
Porcine brain-derived peptide preparation investigated for neurotrophic activity in stroke and neurodegenerative research models.
peptide
PT-141 (Bremelanotide)
Cyclic heptapeptide melanocortin receptor agonist investigated in sexual response research and approved for hypoactive sexual desire disorder.
peptide
Kisspeptin-10
Decapeptide fragment of kisspeptin investigated as a probe of hypothalamic GnRH pulse generation and reproductive endocrinology.
peptide
Thymosin Alpha-1
28-amino-acid thymic peptide investigated for immunomodulatory activity in infectious disease and oncology research contexts.
peptide
Epitalon (Epithalon)
Synthetic tetrapeptide developed in St. Petersburg investigated for pineal gland-related signaling and telomerase regulation in preclinical aging research.
Research use only — not medical advice
View the full research-use disclaimer